دورية أكاديمية
Flash glucose monitoring in type 2 diabetes managed with basal insulin in the USA: a retrospective real-world chart review study and meta-analysis.
| العنوان: | Flash glucose monitoring in type 2 diabetes managed with basal insulin in the USA: a retrospective real-world chart review study and meta-analysis. |
|---|---|
| المؤلفون: | Carlson, Anders L, Daniel, Timothy Dilon, DeSantis, Andrea, Jabbour, Serge, Karslioglu French, Esra, Kruger, Davida, Miller, Eden, Ozer, Kerem, Elliott, Tom |
| المصدر: | Division of Endocrinology, Diabetes and Metabolic Diseases Faculty Papers |
| بيانات النشر: | Jefferson Digital Commons |
| سنة النشر: | 2022 |
| المجموعة: | Jefferson Digital Commons (Thomas Jefferson University, Philadelphia) |
| مصطلحات موضوعية: | Diabetes Research Center, Thomas Jefferson University, adult, aged, blood glucose monitoring, body mass, Canada, Canadian, cohort analysis, diabetes mellitus, female, flushing, glucose blood level, glycemic control, glycemic index, groups by age, health care system, human, hypoglycemia, insulin dependent diabetes mellitus, insulin resistance, insulin treatment, lifestyle modification, male, medical record review, meta analysis, non insulin dependent diabetes mellitus, outcome assessment, prospective study, randomized controlled trial (topic) |
| الوصف: | INTRODUCTION: Evidence supporting use of continuous glucose monitoring in type 2 diabetes treated with basal insulin is unclear. This real-world study aimed to assess the impact on glycated hemoglobin (HbA1c) of flash glucose monitoring use in adults with type 2 diabetes managed with basal insulin. RESEARCH DESIGN AND METHODS: Medical records were reviewed for adult individuals with type 2 diabetes using basal insulin for ≥1 year with or without additional antihyperglycemic medication, HbA1c 8.0%-12.0% prior to FreeStyle Libre Flash Glucose Monitoring use for ≥90 days and an HbA1c measurement recorded between 90 and 194 days after device use. Exclusion criteria included utilization of bolus insulin. Meta-analysis data are from the current study (USA) and a similar Canadian cohort. RESULTS: Medical record analysis (n=100) from 8 USA study sites showed significant HbA1c decrease of 1.4%±1.3%, from 9.4%±1.0% at baseline to 8.0%±1.2% after device use, p CONCLUSIONS: In a real-world retrospective USA study and a meta-analysis of a larger USA and Canada cohort, HbA1c significantly reduced in basal insulin-treated type 2 diabetes, without bolus insulin initiation and following the commencement of flash glucose monitoring technology. |
| نوع الوثيقة: | article in journal/newspaper |
| وصف الملف: | application/pdf |
| اللغة: | English |
| العلاقة: | https://jdc.jefferson.edu/endocrinologyfp/5Test; https://jdc.jefferson.edu/cgi/viewcontent.cgi?article=1005&context=endocrinologyfpTest |
| الإتاحة: | https://jdc.jefferson.edu/endocrinologyfp/5Test https://jdc.jefferson.edu/cgi/viewcontent.cgi?article=1005&context=endocrinologyfpTest |
| حقوق: | http://creativecommons.org/licenses/by-nc/4.0Test/ |
| رقم الانضمام: | edsbas.3A6E004F |
| قاعدة البيانات: | BASE |
| الوصف غير متاح. |